BIONET Therapeutics Corp.
Update：2025/12/24
Industries
Main Industry
Biotechnology
Main Product/Service
At BIONET Therapeutics Corp., our focus is on regenerative medicinal products, Advanced tech-enabled research and development, exosomes, and gene/cell therapy.
Founded Year
2022
Unified Business No.
90272474
Status
Active
Number of Employees
0
Total Paid-in
Capital
700,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2024)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
BIONET Therapeutics Corp. is a patient-focused, R&D-driven global biopharmaceutical company, established in 2022. Our mission is to rapidly develop, manufacture, and provide regenerative medicine preparations and advanced cellular therapies to meet the ev
